Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Open-Label Comparison Study on the Efficacy and Safety of Argatroban Monotherapy With Argatroban-Edaravone Combination Therapy

NCT00153946 is registered in ClinicalTrials.gov with Combination Therapy for Acute Ischemic Stroke Study Group as lead sponsor.

NCT NCT00153946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Open-Label Comparison Study on the Efficacy and Safety of Argatroban Monotherapy With Argatroban-Edaravone Combination Therapy
Lead sponsor
Combination Therapy for Acute Ischemic Stroke Study Group
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2004
Completion date
May 31, 2008
Enrollment
814 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke